Alzheimer’s disease
21
Jul
Alzheimer’s disease Subject: Science and Tech Context: The FDA acknowledged there was not sufficient evidence that the drug would help patients. Instead, it said it was greenlighting Aduhelm under a program called “accelerated approval,. Concept: The Food and Drug Administration’s deadline to decide whether to approve Biogen’s controversial Alzheimer’s drug aducanumab, a council of […]